Key result
Higher annual HF admissions per cardiologist linked to ~4% higher in-hospital mortality per 50 admissions.
Why the study?
While hospital volume is thought to associate with quality of care and outcomes in heart failure, whether annual heart failure admissions per cardiologist associate with process of care, mortality, and readmission was unclear.
Does higher annual patient volume per cardiologist worsen process of care and clinical outcomes in adult patients with heart failure?
Observational (n=1,127,113)
Yes
Does higher annual patient volume per cardiologist worsen process of care and clinical outcomes in adult patients with heart failure?
Higher annual heart failure patient volume per cardiologist (especially >300/year) is associated with worse guideline-directed medical therapy prescription rates and increased mortality and readmission risks.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cardiologist caseload effects on HF outcomes; should not yet change practice or staffing policies.
AIMS: The impact of hospital volume on clinical performance has been investigated by many researchers to date and thought that it is associated with quality of care and outcome for patients with heart failure (HF). This study sought to determine whether annual admissions of HF per cardiologist are associated with process of care, mortality, and readmission. METHODS AND RESULTS: Among the nationwide registry 'Japanese registry of all cardiac and vascular diseases - diagnostics procedure combination' data collected from 2012 to 2019, a total of 1 127 113 adult patients with HF and 1046 hospitals were included in the study. Primary outcome was in-hospital mortality, and secondary outcome was 30 day in-hospital mortality and readmission at 30 days and 6 months. Hospital and patient characteristics and process of care measures were also assessed. Mixed-effect logistic regression and Cox proportional-hazards model was used for multivariable analysis, and adjusted odds ratio and hazard ratio were evaluated. Process of care measures had inverse trends for annual admissions of HF per cardiologist (P < 0.01 for all measures: prescription rate of beta-blocker, angiotensin converting enzyme inhibitor or angiotensin II receptor blocker, mineralocorticoid receptor antagonist, and anticoagulant for atrial fibrillation). Adjusted odds ratio for in-hospital mortality was 1.04 (95% confidence interval (CI): 1.04-1.08, P = 0.04) and 30 day in-hospital mortality was 1.05 (95% CI: 1.01-1.09, P = 0.01) for interval of 50 annual admissions of HF per cardiologist. Adjusted hazard ratio for 30 day readmission was 1.05 (95% CI: 1.02-1.08, P < 0.01) and 6 month readmission was 1.07 (95% CI: 1.03-1.11, P < 0.01). Plots of the adjusted odds indicated 300 as the threshold of annual admissions of HF per cardiologist for substantial increase of in-hospital mortality risk. CONCLUSIONS: Our findings demonstrated that annual admissions of HF per cardiologist are associated with worse process of care, mortality, and readmission with the threshold for mortality risk increased, emphasizing the optimal proportion of patients admitted with HF to cardiologist for better clinical performance.
No takes yet. Share an insight, caveat, or question.
Nishi et al. (2023) conducted an observational in Heart failure (n=1,127,113). Annual admissions of heart failure per cardiologist was evaluated on In-hospital mortality (OR 1.04, 95% CI 1.04-1.08, p=0.04). Higher annual admissions of heart failure per cardiologist (per 50 admissions) were associated with increased in-hospital mortality and worse process of care.
Synapse has enriched 10 related papers. Consider them for comparative context: